GX Pharma is based in Beijing, China. It has raised $60M in total funding. Backed by Lapam Investment, Samsung Venture Investment Corporation (SVIC).
GX Pharma funding overview
GX Pharma is based in Beijing, China. GX Pharma has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for GX Pharma runs through 2025; nothing later has been disclosed. Investors on record include Lapam Investment, Samsung Venture Investment Corporation (SVIC), Guofang Innovation, Hankang Venture Capital, Songqing Capital, Jifeng Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.
GX Pharma has raised $60M in total disclosed funding across the rounds on record.
Who has invested in GX Pharma?
Lapam Investment, Samsung Venture Investment Corporation (SVIC), Guofang Innovation, Hankang Venture Capital, Songqing Capital, Jifeng Ventures are named among the investors backing GX Pharma.
What was the latest GX Pharma funding round?
No round stage has been disclosed for GX Pharma.
Where is GX Pharma based?
GX Pharma is based in Beijing, China.
When did GX Pharma last raise?
The last disclosed GX Pharma round closed in November 2025.
Totals shown for GX Pharma aggregate every disclosed round on file. To see how that compares, browse the companies in Beijing and the investors behind them below.
